Socially Responsible Investing

To Bayer, sustainability means safeguarding our future viability and, as part of corporate strategy, is integrated into everyday procedures. We want to safeguard our company’s long-term success in balance with ecological and societal responsibility.

We attach great importance to dialogue with our stakeholders. We continue our dialogue about our sustainability commitment with market participants whose investment decisions are aligned to ecological, social and governance criteria - through targeted one-on-one meetings, conference calls and roadshows. The Sustainability & Business Stewardship department, in coordination with the Investor Relations department, is in charge of informing socially responsible investors and rating agencies.

We inform our stakeholders on non-financial information and performance indicators in our integrated Annual Report.

Please find below the links to more information on selective sustainability focus topics - for example on the demands made on good corporate governance, our measures of product safety, or our access to healthcare initiatives, etc.

Compliance at BayerCorporate GovernanceRisk Management
Supply Chain
Product Stewardship
Access to Medicine

 

Clinical Studies Bee Care InitiativesSmallholder FarmersClimate Change Responsible Marketing
Genetic Engineering

 

To us, sustainability means safeguarding our future social and economic viability. Understood in this context and as a part of our corporate strategy, sustainability is integrated into our day-to-day procedures.

The steadily growing and aging global population presents fundamental challenges in health care and nutrition. Alongside our goal of achieving economic success, we also seek to make a responsible contribution to the United Nations Sustainable Development Goals of “Good Health and Well-Being” and “Zero Hunger” within the scope of our entrepreneurial possibilities.

We underline our mission as a company that acts sustainably through our commitment to the U.N. Global Compact and the Responsible Care™ initiative, and through our active global involvement in leading initiatives such as the World Business Council for Sustainable Development (WBCSD).

More on our sustainability strategy

To advance the consistent implementation of our strategy, we have set ambitious group targets along the value chain. These targets are in the areas of growth and profitability, innovation, sustainability and employees.

More on our sustainability targets and performance indicators

As part of Bayer’s corporate strategy, sustainability is firmly established at Board level. Responsibility for the Group’s sustainable orientation lies with the Board of Management member responsible for Human Resources, Technology and Sustainability in his role as Chief Sustainability Officer, and with the Sustainable Development Committee (SDC) under the auspices of the Health, Safety & Sustainability function.

The SDC sets targets and draws up initiatives, management systems and corporate policies, and is responsible for their implementation. Operational implementation is effected with the help of nonfinancial targets and performance indicators throughout the value chain, based on a clear definition of responsibilities in the corporate structure and the identification of major areas of activity using a materiality analysis. Corporate policies ensure our sustainability principles are firmly established in business operations and are implemented through corresponding management systems, committees and processes. The review and revision of these regulations and internal audits ensure that our management systems are continuously improved and aligned to the respective requirements.

More on sustainability management

With the Annual Report 2013 we combined our financial and our sustainability reporting for the first time. Our aim in integrating the two previous publications is to elucidate the interactions between financial, ecological and societal factors and underline their influence on our company’s long-term development.

The Bayer Group’s sustainability reporting has been aligned to the guidelines of the Global Reporting Initiative (GRI) and the 10 principles of the U.N. Global Compact (UNGC) since 2000. The Annual Report 2017 was prepared in accordance with the “comprehensive” option of the GRI-G4 Guidelines. The detailed GRI content index with the corresponding UNGC principles can be found in the augmented online version of the Annual Report under “C Further Information.” This report also serves as a Communication on Progress (COP) in line with the U.N. Global Compact.

More on G4 Content Index of the Global Reporting Initiative (GRI) with the 10 Principles of the U.N. Global Compact

You can find more detailed information about the integration of sustainability into our business practices as well as financial and non-financial key figures for previous years in our former integrated annual reports and former sustainable development reports.

More on sustainable development reports

Bayer’s inclusion in the FTSE4Good (Europe, Global and Environmental Leaders Europe 40), important sustainability indices, was confirmed. Bayer also continues to be listed on the MSCI World Low Carbon Target Index, the STOXX® Europe Sustainability Index and the STOXX® Global ESG Impact index. In addition, in 2017 Bayer was again evaluated by the CDP (Carbon Disclosure Project) as one of the leading international pharmaceutical companies in the areas of climate protection and sustainable water management.

IndexZone
FTSE4Good Environmental Leaders Europe 40Europe
FTSE4Good EuropeEurope
FTSE4Good GlobalWorld
MSCI ACWI Low Carbon Target IndexWorld
STOXX® Europe SustainabilityEurope
STOXX® Global ESG ImpactWorld

   More on sustainability ratings and rankings

Services